Mallinckrodt Pharma Ip Trading Limited
Summary
Mallinckrodt Pharma Ip Trading Limited was set up on Monday the 21st of September 2015. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 19 other Irish companies between them; 9 of which are now closed. Mallinckrodt Pharma Ip Trading Limited has 1 shareholder.
Credit Score
- Latest Credit Movement:
- Date of Last Movement:08/10/2024
- Latest Accounts Filed:20/09/2024
- Report Based On Accounts:29/12/2023
- Next Set of Accounts Due:30/09/2025
- Overdue:No
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Mallinckrodt Pharma Ip Trading Limited
- Time in Business:9 Years
- Company Number:568588
- Company Size:Micro Company
- Current Status:NORMAL
- Principal Activity:[6420] Activities of Holding Companies
- May Trade As:Mallinckrodt Pharma Ip Trading Ltd
- Registered Address:College Business & Technology Park,
Cruiserath,
Blanchardstown Dublin 15,
Dublin 15, Dublin
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Judgments
Discover poor payment histories of any company by searching our Judgment Database, for court actions brought against a company for non-payment of a debt. Plus get free Judgment monitoring alerts on this company for the next 12 months. Judgments are available as part of the Credit Report.
Documents
Document | Pages | Effective | Received | Buy |
---|---|---|---|---|
C3 Certificate | 1 | 13/11/2024 | 28/11/2024 | |
C3 Certificate | 1 | 13/11/2024 | 28/11/2024 | |
C3 Certificate | 1 | 13/11/2024 | 28/11/2024 | |
C3 Certificate | 1 | 13/11/2024 | 28/11/2024 | |
C3 Certificate | 1 | 14/11/2023 | 28/11/2024 | |
AMENDED CONSTITUTION | 28 | 27/09/2024 | 02/10/2024 | |
Form B1C - Annual Return General | 12 | 12/08/2024 | 20/09/2024 | |
Certificate of Incorporation | 2 | 21/09/2015 | 14/09/2015 |